AAL-993 is a novel, orally bioavailable and highly potent VEGFR inhibitor that inhibits VEGFR1, 2, and 3 with IC50 values of 130, 23, and 18 nM, respectively.

Chromeceptin is a novel and potent IGF2 inhibitor,it inhibits the phosphorylation levels of AKT and mTOR.

GSK046 (iBET-BD2) is a novel, potent, selective and orally bioactive inhibitor of BET with IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively.

LQVTDSGLYRCVIYHPP (LP17) TFA is a novel triggering receptor expressed on myeloid cells (TREM-1) inhibitory peptide.

Ganirelix acetate is a peptide compound.

Protein kinase inhibitor H-7 is a novel and potent PKC (protein kinase C) inhibitor.

VO-OHpic is an inhibitor of PTEN (phosphatase and tensin homologue deleted on chromosome 10).

VLX600 is a cell-permeable anticancer agent.

Isoxanthohumol is a novel and potent analogue of xanthohumol.

Vardenafil HCl Trihydrate (formerly also known as BAY 38-9456, trade names Levitra; Staxyn; Vivanza) is an approved medication acting as a phosphodiesterase/PDE inhibitor with important biological activity.